MILESTONE PHARMACEUTICALS IN
MISTNASDAQ🏆 #4077 by market capEarnings Nov 10US Equity
$871.43▼ $42.18 (−4.84%)
Simulated priceTrack MIST
Get earnings, price moves & breaking news on Telegram
24h▼ 4.8%
7d—
14d—
30d—
ytd—
1y—
🏦Market Cap
$102M
Small Cap
📈Revenue Growth (YoY)
+0.0%
Slowing
📊Gross Margin
94.6%
High
💵FCF Margin
-2612.7%
Thin
⚖️P/S Ratio
43.6x
Expensive
Otter Score
72
Fair
MILESTONE PHARMACEUTICALS IN
MISTAnalyst Ratings
Price
$871.43
Total
7
Raised
1
Lowered
1
Avg PT
$4.50
H / L
$6 / $3
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
HC Wainwright & Co. | Reiterated | Buy | 2026-09-03 | — | — |
Wells Fargo | Reiterated | Overweight | 2026-05-14 | $8.00 | −99.10% |
TD Cowen | Upgraded | Hold → Buy | 2025-12-15 | — | — |
Piper Sandler | Reiterated | Overweight | 2024-03-05 | $10.00 | −98.90% |
Jefferies | Downgraded | Buy → Hold | 2023-06-20 | — | — |
Oppenheimer | Reiterated | Outperform | 2023-04-12 | — | — |
Piper Jaffray | Reiterated | Overweight | 2019-06-03 | — | — |
Institution
HC Wainwright & Co.
Reiterated · Buy · 2026-09-03
—
—
Wells Fargo
Reiterated · Overweight · 2026-05-14
$8.00
−99.10%
TD Cowen
Upgraded · Hold → Buy · 2025-12-15
—
—
Piper Sandler
Reiterated · Overweight · 2024-03-05
$10.00
−98.90%
Jefferies
Downgraded · Buy → Hold · 2023-06-20
—
—
Oppenheimer
Reiterated · Outperform · 2023-04-12
—
—
Piper Jaffray
Reiterated · Overweight · 2019-06-03
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space